What You Should Know:
– Eko Health, Eko Health, a global leader in AI-enabled cardiopulmonary care, today announced its launch in the United Kingdom—one of the world’s largest healthcare markets. UK clinicians can now purchase Eko’s CORE 500™ Digital Stethoscope, Eko+ Membership, and accessories through EkoHealth.com and Amazon UK, expanding access to AI-powered tools designed to support earlier detection of cardiovascular and respiratory disease.
– This expansion builds on Eko’s international momentum and collaborations with UK institutions, including Imperial College London, where Eko’s technology supports earlier detection of heart disease in frontline care.
Eko Health Expands Global Reach with AI-Powered Cardiac and Pulmonary Care Tools
Eko Health is a leading digital health company transforming how clinicians detect and manage heart and lung disease. Through its suite of digital stethoscopes, AI-enabled software, and integrated provider-patient platforms, Eko empowers over 600,000 healthcare professionals worldwide to diagnose earlier, manage treatment more effectively, and elevate standards of care. Headquartered in Emeryville, California, Eko has raised more than $165 million in funding from a range of top-tier investors including ARTIS Ventures, Mayo Clinic, LG Technology Ventures, and Questa Capital.
Eko’s recent expansion into the UK healthcare market marks a pivotal step in broadening access to high-quality digital auscultation technology. “Bringing Eko’s AI-powered technology directly to UK healthcare professionals represents an exciting step forward in expanding access to high-quality digital auscultation tools,” noted David Bakey, General Manager of Consumer at Eko Health. Clinicians in the UK can now access the company’s flagship CORE 500™ Digital Stethoscope, Eko+ Membership, and a full range of accessories through EkoHealth.com, the Apple App Store, and Google Play.
The CORE 500™ is Eko’s most advanced digital stethoscope, engineered to enhance both in-person and remote clinical workflows. Key features include:
- Three listening modes: wide, cardiac, and pulmonary
- Simultaneous visualization of ECG and heart sounds
- Active noise cancellation for use in high-traffic environments
- Seamless integration with Eko’s mobile application for secure data capture and sharing
The Eko+ Membership augments stethoscope functionality with advanced AI diagnostics, offering tools such as:
- Automated detection of heart murmurs, atrial fibrillation, tachycardia, and bradycardia
- Real-time waveform visualization and multi-point auscultation guidance
- Secure audio recording and sharing capabilities for remote collaboration and second opinions
Eko’s UK launch reflects the growing demand for digital and AI-supported solutions across general practice, urgent care, cardiology, and community health settings. As pressure on healthcare systems increases, tools that can support early detection and confident diagnosis at the point of care are becoming indispensable.
With its expanding global footprint and continued focus on AI-powered innovation, Eko Health is redefining the frontlines of cardiovascular and pulmonary care—one heartbeat at a time.
